Literature DB >> 33315491

By Releasing the Brakes With Immunotherapy, Are We Accelerating Atherosclerosis?

Lavanya Kondapalli1, Wendy Bottinor2, Carrie Lenneman3.   

Abstract

Entities:  

Keywords:  Editorials; T-lymphocytes; coronary artery disease; immunotherapy; inflammation

Year:  2020        PMID： 33315491     DOI： 10.1161/CIRCULATIONAHA.120.051753

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues.

Authors:  Roshni Bhatnagar; Neal M Dixit; Eric H Yang; Tamer Sallam
Journal:  Front Cardiovasc Med       Date:  2022-08-09

Review 2.  Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.

Authors:  Andrew J Murphy; Mark A Febbraio
Journal:  Nat Rev Immunol       Date:  2021-07-20       Impact factor: 53.106

3.  Myricetin ameliorates ox-LDL-induced HUVECs apoptosis and inflammation via lncRNA GAS5 upregulating the expression of miR-29a-3p.

Authors:  Yunpeng Bai; Xiankun Liu; Qingliang Chen; Tongyun Chen; Nan Jiang; Zhigang Guo
Journal:  Sci Rep       Date:  2021-10-04       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.